Answers are grounded in this paper and cite their sources.
Could the immunomodulatory drugs that have produced impressive outcomes in cancer be used to boost immunity to counter infection in the context of sepsis? Recent findings in animal models provide some support for this strategy.
No takes yet. Share an insight, caveat, or question.
Hotchkiss et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: